Btr Capital Management Inc Bristol Myers Squibb CO Transaction History

Btr Capital Management Inc

$641 Million
Q3 2022

A detailed history of Btr Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Btr Capital Management Inc holds 5,040 shares of BMY stock, worth $203,918. This represents 0.06% of its overall portfolio holdings.

Number of Shares

5,040

Previous 5,040 -0.0%

Holding current value

$203,918

Previous $391,000 8.44%

% of portfolio

0.06%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	BUY	$72.62 - $79.98 $4,720 - $5,198	65 Added 1.31%	5,040 $391,000
Q1 2022 May 02, 2022	BUY	$61.48 - $73.72 $4,918 - $5,897	80 Added 1.63%	4,975 $363,000
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $41,563 - $48,453	-775 Reduced 13.67%	4,895 $305,000
Q3 2021 Oct 18, 2021	SELL	$59.17 - $69.31 $22,188 - $25,991	-375 Reduced 6.2%	5,670 $335,000
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $92,865 - $101,130	1,500 Added 33.0%	6,045 $404,000

Q1 2021 Apr 08, 2021	SELL	$59.34 - $66.74 $13,351 - $15,016	-225 Reduced 4.72%	4,545 $287,000
Q4 2020 Jan 12, 2021	BUY	$57.74 - $65.43 $29,158 - $33,042	505 Added 11.84%	4,770 $296,000
Q3 2020 Oct 15, 2020	SELL	$57.43 - $63.64 $17,229 - $19,092	-300 Reduced 6.57%	4,265 $257,000
Q1 2020 Apr 21, 2020	SELL	$46.4 - $67.43 $32,480 - $47,201	-700 Reduced 13.3%	4,565 $254,000
Q4 2019 Jan 17, 2020	BUY	$49.21 - $64.19 $61,512 - $80,237	1,250 Added 31.13%	5,265 $338,000
Q3 2019 Oct 21, 2019	BUY	$42.77 - $50.71 $171,721 - $203,600	4,015 New	4,015 $203,000
Q2 2019 Jul 18, 2019	SELL	$44.62 - $49.34 $194,766 - $215,369	-4,365 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$48.76 - $63.23 $4,876 - $6,323	-100 Reduced 2.24%	4,365 $227,000
Q2 2018 Aug 01, 2018	SELL	$50.53 - $62.98 $1,768 - $2,204	-35 Reduced 0.78%	4,465 $247,000
Q1 2018 May 01, 2018	SELL	$59.92 - $68.98 $33,135 - $38,145	-553 Reduced 10.94%	4,500 $285,000
Q4 2017 Jan 31, 2018	BUY	$59.94 - $65.35 $20,979 - $22,872	350 Added 7.44%	5,053 $310,000
Q3 2017 Oct 27, 2017	BUY	$55.23 - $63.74 $259,746 - $299,769	4,703	4,703 $300,000

Others Institutions Holding BMY

# of Institutions

2,541

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Btr Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Btr Capital Management Inc with notifications on news.

Account

Btr Capital Management Inc Bristol Myers Squibb CO Transaction History